Skip to main content
Caplight Logo









MimiVax Inc.

MimiVax Inc.

Private
Buffalo, New YorkHealthcare & Life Scienceshttps://www.mimivax.com/

Last Round

Debt

Jul 16, 2024

Total Funding Raised

$10M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

MimiVax Inc. is a biotechnology company that develops immunotherapeutic vaccines and targeted therapies designed to control tumor growth and recurrence.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

cancer vaccineSurVaxMimmunotherapypeptide vaccineglioblastomasurvivin targetbiopharma licensingclinical stage biotechmultiple myelomaneuroendocrine tumorsdrug developmentpediatric brain tumors

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MimiVax Inc. Comparables

Compare MimiVax Inc. with similar companies based on industry and business-model similarity.

MimiVax Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Imvax
82%
iOncologi
80%
Diakonos Oncology
80%

MimiVax Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtJul 16, 2024
VC RoundJan 9, 2024
Corporate FundingNov 18, 2019
GrantJan 1, 2013

Key People

Founding team and executive leadership

Michael Ciesielski

President & CEO

Executive Team

MimiVax Inc. Investors

Notable investors and investment history

MimiVax Inc. investors
InvestorRounds
MEDA AngelsVC Round
Varia VenturesVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 21, 2026

    Monthly visitors increased 39% MoM.

  • May 16, 2026

    Monthly visitors increased 270% MoM.

MimiVax Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MimiVax Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MimiVax Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersBuffalo, New York
Employee Range3
Year Founded2012
Last FundingJul 16, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?